Assessing Oral Medication Adherence and Identifying Predictors of Low Adherence in Chinese Inflammatory Bowel Disease Patients

References

• Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-Pacific Crohn’s and colitis epidemiology study. Gastroenterology. 2013;145(1):158–165.e2. doi:10.1053/j.gastro.2013.04.007
   PubMed Web of Science ®Google Scholar
• Gomollón F, Dignass A, Annese V, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 1: diagnosis and medical management. J Crohn’s Colitis. 2017;11(1):3–25. doi:10.1093/ecco-jcc/jjw168
   Google Scholar
• Kane SV, Chao J, Mulani PM. Adherence to infliximab maintenance therapy and health care utilization and costs by Crohn’s disease patients. Adv Ther. 2009;26(10):936–946. doi:10.1007/s12325-009-0069-7
   PubMed Web of Science ®Google Scholar
• Higgins PDR, Rubin DT, Kaulback K, Schoenfield PS, Kane SV. Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares. Aliment Pharmacol Ther. 2009;29(3):247–257. doi:10.1111/j.1365-2036.2008.03865.x
   PubMed Web of Science ®Google Scholar
• Tomar SK, Kedia S, Singh N, et al. Higher education, professional occupation, and upper socioeconomic status are associated with lower adherence to medications in patients with inflammatory bowel disease. J Gastroenterol Hepatol. 2019;3:302–309.
   Google Scholar
• Jackson CA, Clatworthy J, Robinson A, Horne R. Factors associated with non-adherence to oral medication for inflammatory bowel disease: a systematic review. Am J Gastroenterol. 2010;105(3):525–539. doi:10.1038/ajg.2009.685
   PubMed Web of Science ®Google Scholar
• Campos S, Portela F, Sousa P, Sofia C. Inflammatory bowel disease: adherence to immunomodulators in a biological therapy era. Eur J Gastroenterol Hepatol. 2016;28(11):1313–1319. doi:10.1097/MEG.0000000000000704
   Web of Science ®Google Scholar
• Coenen S, Weyts E, Ballet V, et al. Identifying predictors of low adherence in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2016;28(5):503–507. doi:10.1097/MEG.0000000000000570
   PubMed Web of Science ®Google Scholar
• Eindor-abarbanel A, Naftali T, Ruhimovich N, et al. Revealing the puzzle of nonadherence in IBD – assembling the pieces. Inflamm Bowel Dis. 2018;24(6):1352–1360. doi:10.1093/ibd/izy013
   Web of Science ®Google Scholar
• Herman ML, Kane SV. Treatment nonadherence in in flammatory bowel disease: identifi cation, scope, and management strategies. Inflamm Bowel Dis. 2015;21:2979–2984. doi:10.1097/MIB.0000000000000581
   PubMed Web of Science ®Google Scholar
• Trindade AJ, Ehrlich A, Kornbluth A, Ullman TA. Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence. Inflamm Bowel Dis. 2011;17(2):599–604. doi:10.1002/ibd.21310
   PubMed Web of Science ®Google Scholar
• Morisky DE, Ang A, Krousel-wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10(5):348–354. doi:10.1111/j.1751-7176.2008.07572.x
   PubMed Web of Science ®Google Scholar
• Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care. 2009;15(1):59–66.
   PubMed Web of Science ®Google Scholar
• Voils CI, Hoyle RH, Thorpe CT, MacIejewski ML, Yancy Jr. WS. Improving the measurement of self-reported medication nonadherence. J Clin Epidemiol. 2011;64(3):250–254. doi:10.1016/j.jclinepi.2010.07.014
   PubMed Web of Science ®Google Scholar
• Hess LM, Raebel MA, Conner DA, Malone DC. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother. 2006;40(7–8):1280–1288. doi:10.1345/aph.1H018
   PubMed Web of Science ®Google Scholar
• BennebroekEvertsz’ F, Nieuwkerk PT, Stokkers PCF, et al. The patient simple clinical colitis activity index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: a comparison of the P-SCCAI with clinician-based SCCAI and biological markers. J Crohn’s Colitis. 2013;7:890–900. doi:10.1016/j.crohns.2012.11.007
   Google Scholar
• Harvey RF, Bradshaw JM. A simple index of Crohn’s-disease activity. Lancet. 1980;315(8167):514. doi:10.1016/S0140-6736(80)92767-1
   Google Scholar
• van der Have M, Oldenburg B, Kaptein AA, et al. Non-adherence to anti-TNF therapy is associated with illness perceptions and clinical outcomes in outpatients with inflammatory bowel disease: results from a prospective multicentre study. J Crohn’s Colitis. 2016;10(5):549–555. doi:10.1093/ecco-jcc/jjw002
   Google Scholar
• Bucci C, Zingone F, Tammaro S, Iovino P, Santonicola A. Factors predicting the adherence to the therapy of Italian IBD patients. Gastroenterol Res Pract. 2017;2017:6719345. doi:10.1155/2017/6719345
   PubMed Web of Science ®Google Scholar
• Robinson A. Review article: improving adherence to medication in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2008;27(Suppl 1):9–14. doi:10.1111/j.1365-2036.2008.03604.x
   PubMed Web of Science ®Google Scholar
• Bruna-Barranco I, Lué A, Gargallo-Puyuelo CJ, et al. Young age and tobacco use are predictors of lower medication adherence in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2019;31(8):948–953. doi:10.1097/MEG.0000000000001436
   Web of Science ®Google Scholar
• Červený P, Bortlík M, Kuběna A, Vlček J, Lakatos PL, Lukáš M. Nonadherence in inflammatory bowel disease: results of factor analysis. Inflamm Bowel Dis. 2007;13(10):1244–1249. doi:10.1002/ibd.20189
   Web of Science ®Google Scholar
• D’Incà R, Bertomoro P, Mazzocco K, Vettorato MG, Rumiati R, Sturniolo GC. Risk factors for non-adherence to medication in inflammatory bowel disease patients. Aliment Pharmacol Ther. 2008;27(2):166–172. doi:10.1111/j.1365-2036.2007.03555.x
   Web of Science ®Google Scholar
• Yu Q, Xu L, Li L, et al. Internet and WeChat used by patients with Crohn’s disease in China: a multi-center questionnaire survey. BMC Gastroenterol. 2019;19(1):97. doi:10.1186/s12876-019-1011-3
   PubMed Web of Science ®Google Scholar
• Kemp K, Dibley L, Chauhan U, et al. Second N-ECCO consensus statements on the European nursing roles in caring for patients with Crohn’s disease or ulcerative colitis. J Crohn’s Colitis. 2018;12(7):760–776. doi:10.1093/ecco-jcc/jjy020
   Google Scholar
• Colombel JF, D’haens G, Lee WJ, Petersson J, Panaccione R. Outcomes and strategies to support a treat-to-target approach in inflammatory bowel disease: a systematic review. J Crohns Colitis. 2020;14(2):254–266. doi:10.1093/ecco-jcc/jjz131
   PubMed Web of Science ®Google Scholar
• Peyrin-Biroulet L, Reinisch W, Colombel JF, et al. Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn’s disease in the SONIC trial. Gut. 2014;63(1):88–95. doi:10.1136/gutjnl-2013-304984
   PubMed Web of Science ®Google Scholar
• Agrawal M, Colombel JF. Treat-to-target in inflammatory bowel diseases, what is the target and how do we treat? Gastrointest Endosc Clin N Am. 2019;29(3):421–436. doi:10.1016/j.giec.2019.02.004
   PubMedGoogle Scholar
• Kane S, Becker B, Harmsen WS, Kurian A, Morisky DE, Zinsmeister AR. Use of a screening tool to determine nonadherent behavior in inflammatory bowel disease. Am J Gastroenterol. 2012;107:154–160. doi:10.1038/ajg.2011.317
   PubMed Web of Science ®Google Scholar
• McCarney R, Warner J, Iliffe S, van Haselen R, Griffin M, Fisher P. The Hawthorne effect: a randomised, controlled trial. BMC Med Res Methodol. 2007;7:30. doi:10.1186/1471-2288-7-30
   PubMed Web of Science ®Google Scholar
• Sewitch MJ, Abrahamowicz M, Barkun A, et al. Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol. 2003;98(7):1535–1544. doi:10.1111/j.1572-0241.2003.07522.x
   PubMed Web of Science ®Google Scholar
• Selinger CP, Eaden J, Brian Jones D, et al. Modifiable factors associated with nonadherence to maintenance medication for inflammatory bowel disease. Inflamm Bowel Dis. 2013;19(10):2199–2206. doi:10.1097/MIB.0b013e31829ed8a6
   PubMed Web of Science ®Google Scholar